Verdezyne Gets $1.7M Grant

Bruce V. Bigelow10/19/09

[Corrrected 10/22/09, 11:30 a.m. to show Coda Genomics instead of Coda Genetics] Carlsbad CA-based Verdezyne, a synthetic biology company previously known as CODA Genomics, says it has received a $1.7 million Small Business Technology Transfer grant to develop mutant gene libraries for its computational and bioinformatics programs. The venture-backed startup says identifying such genes will enhance the metabolic engineering tools needed in its biofuels and chemical production programs. The grant came through the National Institute of Allergy and Infectious Diseases, and Verdezyne says its libraries also will be useful to life sciences researchers.

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call (619) 669-8788